Aminex Therapeutics, Inc.
BiotechnologyImmuno-oncology drug development
Kenmore, WA
About
Aminex Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel immuno-oncology therapies. Their primary strategy is to overcome immune system suppression within the tumor microenvironment by targeting and depleting polyamines, thereby enabling the body's own immune system to attack cancer cells.
Company Values
The company is a pioneer in developing a therapeutic approach based on polyamine depletion, which addresses two key immune suppressors—polyamines and myeloid-derived suppressor cells (MDSCs)—with a single combination therapy.